H. Weiss

发表

Preclinical characterization of 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]benzoic acid metabolism: in vitro species comparison and in vivo disposition in rats.

K. Cassidy, E. Perkins, D. A. Jackson, 2003, Drug metabolism and disposition: the biological fate of chemicals.

Impaired platelet-connective-tissue reaction in man after aspirin ingestion.

L. Aledort, H. Weiss, H. Weiss, 1967, Lancet.

Content and thrombin-induced release of acid hydrolases in gel-filtered platelets from patients with storage pool disease.

H. Holmsen, B. Lages, M. Scrutton, 1975, Blood.

Thrombin and ionophore A23187-induced dense granule secretion in storage pool deficient platelets: evidence for impaired nucleotide storage as the primary dense granule defect.

C. Dangelmaier, H. Holmsen, B. Lages, 1983, Blood.

Platelet malondialdehyde production and aggregation responses induced by arachidonate, prostaglandin-G2, collagen, and epinephrine in 12 patients with storage pool deficiency

B. Lages, H. Weiss, 1981 .

Studies of platelet 5-hydroxytryptamine (serotonin) in storage pool disease and albinism.

T. Tschopp, H. Weiss, J. Rogers, 1974, The Journal of clinical investigation.

A congenital defect in platelet prostaglandin production associated with impaired hemostasis in storage pool disease.

H. Weiss, A. L. Willis, 1973, Prostaglandins.

Platelet alpha granule deficiency associated with decreased P-selectin and selective impairment of thrombin-induced activation in a new patient with gray platelet syndrome (alpha-storage pool deficiency).

B. Lages, D. Coletti, S. P. Levine, 1997, The Journal of laboratory and clinical medicine.

The storage defects in grey platelet syndrome and alphadelta-storage pool deficiency affect alpha-granule factor V and multimerin storage without altering their proteolytic processing.

B. Lages, P. Harrison, C. Hayward, 2001, British journal of haematology.

Acetylenic Analog of Arachidonate That Acts Like Asprinn on Platelets

D. Kuhn, H. Weiss, A. L. Willis, 1974, Science.

The effect of salicylates on the hemostatic properties of platelets in man.

L. Aledort, S. Kochwa, H. Weiss, 1968, The Journal of clinical investigation.

Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome, and storage pool disease.

G. Jamieson, H. Weiss, T. Okumura, 1979, The Journal of laboratory and clinical medicine.

Specific correction of impaired acid hydrolase secretion in storage pool-deficient platelets by adenosine diphosphate.

C. Dangelmaier, H. Holmsen, B. Lages, 1988, The Journal of clinical investigation.

A new von Willebrand variant (type I, New York): increased ristocetin- induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers

H. Weiss, I. Sussman, 1986 .

Metal ion contents of gel-filtered platelets from patients with storage pool disease.

H. Holmsen, B. Lages, M. Scrutton, 1975, Blood.

A Study of the Cation-and pH-Dependent Stability of Factors V and VIII in Plasma*

H. Weiss, H. Weiss, 1965, Thrombosis and Haemostasis.

Type 2B von Willebrand disease and related disorders of patients with increased ristocetin‐induced platelet aggregation: what they tell us about the role of von Willebrand factor in hemostasis

H. Weiss, 2004, Journal of thrombosis and haemostasis : JTH.

Decreased content and surface expression of alpha-granule membrane protein GMP-140 in one of two types of platelet alpha delta storage pool deficiency.

D. Bainton, S. Shattil, B. Lages, 1991, The Journal of clinical investigation.

Studies of thromboxane B2, platelet factor 4, and fibrinopeptide A in bleeding-time blood of patients deficient in von Willebrand factor, platelet glycoproteins Ib and IIb-IIIa, and storage granules.

H. Weiss, B. Lages, H. Weiss, 1993, Blood.